Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
作者信息
Palmeira Vitória Andrade, Costa Larissa Braga, Perez Lucas Giandoni, Ribeiro Victor Teatini, Lanza Katharina, Silva Ana Cristina Simões E
机构信息
Laboratorio Interdisciplinar de Investigacao Medica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, BR.
出版信息
Clinics (Sao Paulo). 2020;75:e1928. doi: 10.6061/clinics/2020/e1928. Epub 2020 May 8.
Abstract
摘要
相似文献
1
Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?我们是否有足够的证据将氯喹/羟氯喹用作应对新冠病毒病的公共卫生万能药？
Clinics (Sao Paulo). 2020;75:e1928. doi: 10.6061/clinics/2020/e1928. Epub 2020 May 8.
2
Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).关于氯喹/羟氯喹治疗 2019 年冠状病毒病（COVID-19）的最新情况。
Biosci Trends. 2020 May 21;14(2):156-158. doi: 10.5582/bst.2020.03072. Epub 2020 Apr 13.
3
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹用于治疗新型冠状病毒肺炎的安全性考量
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
4
Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.氯喹和羟氯喹在2019冠状病毒病中的应用：资源匮乏地区面临的挑战及谨慎使用的必要性
J Coll Physicians Surg Pak. 2020 Jun;30(6):78. doi: 10.29271/jcpsp.2020.Supp1.S78.
5
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.新型冠状病毒肺炎防治：氯喹和羟氯喹临床药理学的批判性分析。
PLoS Med. 2020 Sep 3;17(9):e1003252. doi: 10.1371/journal.pmed.1003252. eCollection 2020 Sep.
6
Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19.新型冠状病毒肺炎中羟氯喹低剂量肺部给药的新方法。
Br J Pharmacol. 2020 Nov;177(21):4997-4998. doi: 10.1111/bph.15167. Epub 2020 Jul 13.
7
COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?2019冠状病毒病与氯喹/羟氯喹：是否存在眼科方面的问题？
Am J Ophthalmol. 2020 Aug;216:A1-A2. doi: 10.1016/j.ajo.2020.03.029. Epub 2020 May 8.
8
Chloroquine and hydroxychloroquine repositioning in times of COVID-19 pandemics, all that glitters is not gold.在新冠疫情期间氯喹和羟氯喹的重新定位，并非所有闪光的东西都是金子。
Cad Saude Publica. 2020;36(5):e00088520. doi: 10.1590/0102-311x00088520. Epub 2020 May 18.
9
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
10
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.抗2019冠状病毒病（COVID-19）的氨基喹啉：氯喹或羟氯喹。
Int J Antimicrob Agents. 2020 Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.
引用本文的文献
1
Implementation of platform trials in the COVID-19 pandemic: A rapid review.新冠疫情期间平台试验的实施：快速综述。
Contemp Clin Trials. 2022 Jan;112:106625. doi: 10.1016/j.cct.2021.106625. Epub 2021 Nov 15.
2
Medicines and illusions in the fight against COVID-19 in Brazil.巴西抗击新冠疫情中的药物与幻想
Ethics Med Public Health. 2021 Mar;16:100622. doi: 10.1016/j.jemep.2020.100622. Epub 2021 Jan 1.
3
COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases.COVID-19、羟氯喹和心脏性猝死：对风湿性疾病患者临床实践的影响。
Rheumatol Int. 2021 Feb;41(2):257-273. doi: 10.1007/s00296-020-04759-2. Epub 2021 Jan 1.
4
Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?将西格玛-1受体配体重新用于治疗新冠病毒肺炎？
Front Pharmacol. 2020 Nov 9;11:582310. doi: 10.3389/fphar.2020.582310. eCollection 2020.
5
Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations.来自人脐带组织的现成间充质干细胞可显著改善新冠病毒肺炎患者的症状：证据关系分析
World J Stem Cells. 2020 Aug 26;12(8):721-730. doi: 10.4252/wjsc.v12.i8.721.
6
Lysenko and the Screwworm Fly-When Politics Interferes with Science and Public Health.李森科与螺旋蝇——当政治干扰科学与公共卫生事业时。
Int J Environ Res Public Health. 2020 Sep 14;17(18):6687. doi: 10.3390/ijerph17186687.
本文引用的文献
1
Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes.使用氯喹进行COVID-19临床试验的驱动因素：选择正确研究问题和结果的必要性。
Rev Soc Bras Med Trop. 2020 Apr 6;53:e20200155. doi: 10.1590/0037-8682-0155-2020. eCollection 2020.
2
Chloroquine and hydroxychloroquine binding to melanin: Some possible consequences for pathologies.氯喹和羟氯喹与黑色素的结合：对病理学的一些可能影响。
Toxicol Rep. 2014 Nov 4;1:963-968. doi: 10.1016/j.toxrep.2014.10.019. eCollection 2014.
3
Thalidomide-induced teratogenesis: history and mechanisms.沙利度胺诱导的致畸作用：历史与机制
Birth Defects Res C Embryo Today. 2015 Jun;105(2):140-56. doi: 10.1002/bdrc.21096. Epub 2015 Jun 4.
4
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.系统评价和荟萃分析议定书的首选报告项目（PRISMA-P）2015：详细说明和解释。
BMJ. 2015 Jan 2;350:g7647. doi: 10.1136/bmj.g7647.
5
Effects of chloroquine on viral infections: an old drug against today's diseases?氯喹对病毒感染的影响：一种治疗当今疾病的老药？
Lancet Infect Dis. 2003 Nov;3(11):722-7. doi: 10.1016/s1473-3099(03)00806-5.
Zotero 插件